We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PNC:NYSEPNC Financial Services Group, Inc. (The) Analysis

Data as of 2026-05-21 - not real-time

$216.08

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

PNC is trading at $216.08, comfortably above its 20‑day SMA of 217.43 but still above the 50‑day SMA of 214.51, indicating a short‑term bullish bias despite a bearish MACD histogram. The RSI sits near 49, suggesting neutral momentum, while the 30‑day volatility of roughly 19% and a beta under 1 point to moderate price swings for a regional bank. Valuation metrics are attractive: a trailing P/E of 12.5 is well below the industry average of 16.6, and the dividend yield of 3.14% with a payout ratio under 40% signals a sustainable income stream. Revenue grew 13.8% YoY, net interest income rose 6%, and average loans expanded 7% in Q1, underscoring solid top‑line momentum. Analysts are broadly positive, with a consensus “Buy” and a mean target of $254, implying about 18% upside from current levels. Overall, the stock appears undervalued relative to peers, offers a healthy dividend, and benefits from recent earnings beat and active share repurchases.
Given the stable liquidity profile, low beta, and supportive fundamentals, the medium‑ to long‑term outlook remains favorable, though the near‑term technical picture is mixed, warranting a cautious hold until price consolidates above the $209.7 support level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at $209.7
  • Bearish MACD histogram despite bullish SMA crossover
  • Neutral RSI indicating no strong momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target price of $254 (~18% upside)
  • Strong earnings beat with NII up 6% and loan growth 7%
  • Attractive valuation multiples versus industry peers

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend yield of 3.14% and low payout ratio
  • Consistent revenue growth and solid operating margins
  • Low beta and stable liquidity supporting defensive profile

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin31.31%
P/E Ratio12.5
ROE12.10%
ROA1.26%
P/B Ratio1.4
Op. Cash Flow$6.8B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI48.8
Support$209.70
Resistance$226.01
MA 20$217.43
MA 50$214.51
MA 200$206.54
MACDBearish
VolumeStable
Fear & Greed Index90.73

Valuation

Fair Value$135.12
Target Price$254.95
Upside/Downside17.99%
GradeUndervalued
TypeBlend
Dividend Yield3.14%

Risk Assessment

Beta0.86
Volatility19.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.